Adenocyte Ltd
General Data
Reg Number
516302361
Sector
Medical Devices
Established
2020
No. of Employees
15
Stage
Initial Revenues
Additional Funding
1
Description
LINFU® enhances the release of epithelial cells from the ductal region of intact ductal cell clusters naturally present in pancreatic fluid .
Technology
MedTech.
Targeted Customers
Oncologists.
Management personnel
Mark Rutenberg - CEO & Founder
Dan Adam - CTO
Scott Korman - CFO
Winning details
Route name
Winning year
R&D Fund
R&D Fund
2023
R&D Fund
R&D Fund
2024